PREVIOUSLY RESPONDING NO-OPTION PATIENTS WITH RESIDUAL OR RECURRENT REFRACTORY ANGINA PECTORIS AND DOCUMENTED ISCHEMIA BENEFIT FROM REPEAT INTRAMYOCARDIAL INJECTION OF AUTOLOGOUS BONE MARROW CELLS